Need for adjustment to the Medicines Act with regard to the permission to manufacture radiopharmaceuticals used as investigational preparations

Summary

Original text of the question(s):<br /> <br /> Does the Federal Government see a need for adjustments to Section 13 Paragraph 2b of the Medicines Act (AMG) to ensure that approved (radioactive) medicines have priority as soon as they are available, and if not, why not?

Machine translation from German. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.